MedTrace Logo

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

NCT03628885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 908

Last updated 2019-04-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate mother's attitudes about vaccinating their 11-14 year old children against the human papillomavirus (HPV). Among mothers who do not plan to vaccinate their child, the investigators will assess the influence of brief videos tailored to mothers' questions and concerns. Mothers will be randomized to one of three arms: 1. General video message about vaccination; 2. General message plus a brief video addressing the mother's primary concern; or 3. General message plus videos address all of mother-indicated concerns. The outcome of interest is intention to vaccinate. Our hypothesis is that the tailored videos will lead to increased intention to vaccinate.

Conditions

  • Human Papilloma Virus Vaccines
  • Attitude to Health

Interventions

BEHAVIORAL

Top Concern Tailored Intervention

General Vaccine Information video plus a brief (\< 50 sec) animated video address the parent's top ranked question or concern from the provided list of possible concerns.

BEHAVIORAL

All Concerns Tailored Intervention

General Vaccine Information video plus one or more brief (\< 50 sec) animated videos that address all of the parent's indicated question or concern from the provided list of possible concerns.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Gregory D Zimet, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-11
Primary Completion
2018-09-27
Completion
2018-09-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628885 on ClinicalTrials.gov